bisantrene has been researched along with Urinary Bladder Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kovach, JS; Powis, G | 1 |
| Alberts, DS; Mackel, C; Pocelinko, R; Salmon, SE | 1 |
| Ahmed, T; Kyriazis, AP; Scher, HI; Watson, RC; Yagoda, A | 1 |
1 trial(s) available for bisantrene and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antineoplastic Agents; Cell Survival; Clinical Trials as Topic; Colony-Forming Units Assay; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Melanoma; Middle Aged; Multiple Myeloma; Neoplasms; Urinary Bladder Neoplasms | 1982 |
2 other study(ies) available for bisantrene and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Disposition of bisantrene in humans and rabbits: evidence for intravascular deposition of drug as a cause of phlebitis.
Topics: Animals; Anthracenes; Colonic Neoplasms; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Phlebitis; Rabbits; Rectal Neoplasms; Urinary Bladder Neoplasms | 1983 |
Experimental studies and phase II trial of bisantrene in advanced urothelial malignancies.
Topics: Aged; Animals; Anthracenes; Antibiotics, Antineoplastic; Bone Marrow; Carcinoma, Transitional Cell; Drug Evaluation; Female; Humans; Male; Mice; Mice, Inbred BALB C; Middle Aged; Urinary Bladder Neoplasms | 1985 |